Table IV.
Reference | Autologous RBC in crossover design
|
RBC characteristics
|
Outcome parameters | Summary of results | Country | Trial registration | ||
---|---|---|---|---|---|---|---|---|
Volun-teers (n) | RBC (n) | RBC storage time | Leuco-reduction | |||||
Weiskopf et al, (2006) | 9 | 2 | 3.4 h versus 23 days (median) | No | Anaemia-induced cognitive dysfunction | No difference in reversal of dysfunction | USA | |
Hod et al, (2011) | 14 | 2 | 3 to 7 days versus 40 to 42 days | Yes | Iron, extravascular haemolysis, metabolism parameters, inflammation, bacterial growth in vitro | Significant changes in iron and extravasular haemolysis parameters only | USA | NCT01319552 |
Berra et al, (2012) | 9 | 1 | 3 days versus 40 days | Yes | Reactive hyperaemia index (reactive hyperperfusion) | No difference in hyperaemia index | USA | |
Weiskopf et al, (2012) | 35 | 2 | 1.7 h versus 24.5 days | Yes | Pulmonary function (gas exchange variables) | Equivalent slight declines in variables | USA |
RBC, red blood cell.